Federal HB3037 prohibits cost-sharing for diagnostic and supplemental breast examinations.

Federal HB3037, the Access to Breast Cancer Diagnosis Act of 2025, amends the Public Health Service Act to prohibit group health plans and health insurance issuers from imposing cost-sharing requirements for diagnostic and supplemental breast examinations. The bill also modifies the Internal Revenue Code to ensure that high deductible health plans with health savings accounts do not fail to qualify due to the absence of a deductible for these examinations. The changes apply to plan years beginning on or after January 1, 2026.

Federal HB3037 prohibits cost-sharing for diagnostic and supplemental breast examinations.

Federal HB3037, the Access to Breast Cancer Diagnosis Act of 2025, amends the Public Health Service Act to prohibit group health plans and health insurance issuers from imposing cost-sharing requirements for diagnostic and supplemental breast examinations. The bill also modifies the Internal Revenue Code to ensure that high deductible health plans with health savings accounts do not fail to qualify due to the absence of a deductible for these examinations. The changes apply to plan years beginning on or after January 1, 2026.